Menu
Log in
Log in

News

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

18 Jul 2025 11:59 AM | Anonymous member (Administrator)

Yelena Y. Janjigian; Salah-Eddin Al-Batran; Zev A. Wainberg; Kei Muro; Daniela Molena; Eric Van Cutsem; Woo Jin Hyung; Lucjan Wyrwicz; Do-Youn Oh; Takeshi Omori; Markus Moehler; Marcelo Garrido; Sulene C.S. Oliveira; Moishe Liberman; Victor Castro Oliden; Elizabeth C. Smyth; Alexander Stein; Mehmet Bilici; Maria Lorena Alvarenga; Vadim Kozlov; Fernando Rivera; Akihito Kawazoe; Olivier Serrano; Eric Heilbron; Alejandra Negro; John F. Kurland; Josep Tabernero

Read Abstract: Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software